technology-commercialization
(2)
The Firm That Buys Fortune 100 Leftovers and Turns Them Into Companies
Big companies spend billions on R&D and then quietly bury most of it. Catalyze Partners digs it back up, staffs it, funds it, and sells it - and lets investors own the whole shelf.
John Joyoprayitno
John Joyoprayitno is the President, CEO, and co-founder of Alafair Biosciences, an Austin-based medical device company building bioresorbable hydrogel implants that protect soft tissue during surgery. A native Austinite who studied anthropology before switching to entrepreneurship, he has built and run ventures ranging from a triathlon bike shop to the custom-car outfit Austin Speed Shop, and now leads a commercial-stage medtech firm best known for its VersaWrap product line. Under his leadership Alafair posted 722% year-over-year growth, and he was named Austin Business Journal's 2024 Best CEO and made Inc.'s 2025 Business Leader of the Year list.